tradingkey.logo

Applied DNA Sciences Inc

APDN
查看詳細走勢圖
5.620USD
0.000
收盤 12/24, 13:00美東報價延遲15分鐘
5.07M總市值
虧損本益比TTM

Applied DNA Sciences Inc

5.620
0.000
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

0.00%

1月

0.00%

6月

+18.07%

今年開始到現在

-44.90%

1年

-37.24%

查看詳細走勢圖

TradingKey Applied DNA Sciences Inc股票評分

單位: USD 更新時間: 2025-10-06

操作建議

Applied DNA Sciences Inc當前公司基本面數據相對非常健康,當前估值合理,機構持股佔比非常高,近一個月多位分析師給出公司評級為。最高目標價max_target_price。近一個月,市場表現很強,但基本面和技術面綜合得分較低,很強的走勢沒有得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Applied DNA Sciences Inc評分

相關信息

行業排名
152 / 207
全市場排名
517 / 4706
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Applied DNA Sciences Inc亮點

亮點風險
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
業績增長期
公司處於發展階段,最新年度總收入3.43M美元
估值高估
公司最新PE估值0.00,處於3年歷史高位
機構加倉
最新機構持股89.41K股,環比增加42.30%
先鋒集團持倉
明星投資者先鋒集團持倉,最新持倉0.00股

Applied DNA Sciences Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Applied DNA Sciences Inc簡介

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
公司代碼APDN
公司Applied DNA Sciences Inc
CEOShorrock (Clay)
網址https://adnas.com/

常見問題

Applied DNA Sciences Inc(APDN)的當前股價是多少?

Applied DNA Sciences Inc(APDN)的當前股價是 5.620。

Applied DNA Sciences Inc 的股票代碼是什麼?

Applied DNA Sciences Inc的股票代碼是APDN。

Applied DNA Sciences Inc股票的52週最高點是多少?

Applied DNA Sciences Inc股票的52週最高點是327.319。

Applied DNA Sciences Inc股票的52週最低點是多少?

Applied DNA Sciences Inc股票的52週最低點是2.130。

Applied DNA Sciences Inc的市值是多少?

Applied DNA Sciences Inc的市值是5.07M。

Applied DNA Sciences Inc的淨利潤是多少?

Applied DNA Sciences Inc的淨利潤為-7.23M。

現在Applied DNA Sciences Inc(APDN)的股票是買入、持有還是賣出?

根據分析師評級,Applied DNA Sciences Inc(APDN)的總體評級為--,目標價格為--。

Applied DNA Sciences Inc(APDN)股票的每股收益(EPS TTM)是多少

Applied DNA Sciences Inc(APDN)股票的每股收益(EPS TTM)是3601.391。
KeyAI